Literature DB >> 23763770

Computational analysis of four human adenovirus type 4 genomes reveals molecular evolution through two interspecies recombination events.

Shoaleh Dehghan1, Jason Seto, Elizabeth B Liu, Michael P Walsh, David W Dyer, James Chodosh, Donald Seto.   

Abstract

Computational analysis of human adenovirus type 4 (HAdV-E4), a pathogen that is the only HAdV member of species E, provides insights into its zoonotic origin and molecular adaptation. Its genome encodes a domain of the major capsid protein, hexon, from HAdV-B16 recombined into the genome chassis of a simian adenovirus. Genomes of two recent field strains provide a clue to its adaptation to the new host: recombination of a NF-I binding site motif, which is required for efficient viral replication, from another HAdV genome. This motif is absent in the chimpanzee adenoviruses and the HAdV-E4 prototype, but is conserved amongst other HAdVs. This is the first report of an interspecies recombination event for HAdVs, and the first documentation of a lateral partial gene transfer from a chimpanzee AdV. The potential for such recombination events are important when considering chimpanzee adenoviruses as candidate gene delivery vectors for human patients.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenovirus; Molecular evolution; Recombination; Zoonosis

Mesh:

Substances:

Year:  2013        PMID: 23763770      PMCID: PMC3779658          DOI: 10.1016/j.virol.2013.05.014

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  87 in total

1.  Natural variation among human adenoviruses: genome sequence and annotation of human adenovirus serotype 1.

Authors:  Kim P Lauer; Isabel Llorente; Eric Blair; Jason Seto; Vladimir Krasnov; Anjan Purkayastha; Susan E Ditty; Ted L Hadfield; Charles Buck; Clark Tibbetts; Donald Seto
Journal:  J Gen Virol       Date:  2004-09       Impact factor: 3.891

2.  Acute respiratory disease in military trainees: the adenovirus surveillance program, 1966-1971.

Authors:  B A Dudding; F H Top; P E Winter; E L Buescher; T H Lamson; A Leibovitz
Journal:  Am J Epidemiol       Date:  1973-03       Impact factor: 4.897

3.  Characterization of four new adenovirus serotypes isolated from chimpanzee tissue explants.

Authors:  M Basnight; N G Rogers; C J Gibbs; D C Gajdusek
Journal:  Am J Epidemiol       Date:  1971-08       Impact factor: 4.897

4.  Immunization by selective infection with type 4 adenovirus grown in human diploid tissue cultures. I. Safety and lack of oncogenicity and tests for potency in volunteers.

Authors:  R M Chanock; W Ludwig; R J Heubner; T R Cate; L W Chu
Journal:  JAMA       Date:  1966-02-07       Impact factor: 56.272

5.  Immunological relationships between hexons of certain human adenoviruses.

Authors:  E Norrby; G Wadell
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

6.  Standardization and certification of reference antigens and antisera for 30 human adenovirus serotypes.

Authors:  D A Stevens; M Schaeffer; J P Fox; C D Brandt; M Romano
Journal:  Am J Epidemiol       Date:  1967-11       Impact factor: 4.897

7.  Terminal dilution purification of adenovirus prototypes, and the antigenic relationship between types 4, 16 and 14.

Authors:  R Wigand
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

8.  The Seattle Virus Watch. VII. Observations of adenovirus infections.

Authors:  J P Fox; C E Hall; M K Cooney
Journal:  Am J Epidemiol       Date:  1977-04       Impact factor: 4.897

9.  Comprehensive detection and serotyping of human adenoviruses by PCR and sequencing.

Authors:  Helen Sarantis; Grant Johnson; Martha Brown; Martin Petric; Raymond Tellier
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

10.  Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans.

Authors:  F H Top; R A Grossman; P J Bartelloni; H E Segal; B A Dudding; P K Russell; E L Buescher
Journal:  J Infect Dis       Date:  1971-08       Impact factor: 5.226

View more
  35 in total

Review 1.  Genomic foundations of evolution and ocular pathogenesis in human adenovirus species D.

Authors:  Ashrafali Mohamed Ismail; Xiaohong Zhou; David W Dyer; Donald Seto; Jaya Rajaiya; James Chodosh
Journal:  FEBS Lett       Date:  2019-12-11       Impact factor: 4.124

2.  Homologous recombination in E3 genes of human adenovirus species D.

Authors:  Gurdeep Singh; Christopher M Robinson; Shoaleh Dehghan; Morris S Jones; David W Dyer; Donald Seto; James Chodosh
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

3.  Simian adenovirus type 35 has a recombinant genome comprising human and simian adenovirus sequences, which predicts its potential emergence as a human respiratory pathogen.

Authors:  Shoaleh Dehghan; Jason Seto; Morris S Jones; David W Dyer; James Chodosh; Donald Seto
Journal:  Virology       Date:  2013-10-08       Impact factor: 3.616

4.  Genomic characterization of human adenovirus type 4 strains isolated worldwide since 1953 identifies two separable phylogroups evolving at different rates from their most recent common ancestor.

Authors:  Gabriel Gonzalez; Camden R Bair; Daryl M Lamson; Hidemi Watanabe; Laura Panto; Michael J Carr; Adriana E Kajon
Journal:  Virology       Date:  2019-09-08       Impact factor: 3.616

Review 5.  Adenovirus infections in immunocompetent and immunocompromised patients.

Authors:  Thomas Lion
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

6.  Inhibition of Human Adenovirus Replication by the Importin α/β1 Nuclear Import Inhibitor Ivermectin.

Authors:  Cason R King; Tanner M Tessier; Mackenzie J Dodge; Jason B Weinberg; Joe S Mymryk
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

7.  Mimicry of Cellular A Kinase-Anchoring Proteins Is a Conserved and Critical Function of E1A across Various Human Adenovirus Species.

Authors:  Cason R King; Steven F Gameiro; Tanner M Tessier; Ali Zhang; Joe S Mymryk
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

8.  Molecular evolution of human adenovirus type 16 through multiple recombination events.

Authors:  Xingui Tian; Hongkai Wu; Rong Zhou
Journal:  Virus Genes       Date:  2019-08-05       Impact factor: 2.332

9.  Construction and evaluation of novel rhesus monkey adenovirus vaccine vectors.

Authors:  Peter Abbink; Lori F Maxfield; David Ng'ang'a; Erica N Borducchi; M Justin Iampietro; Christine A Bricault; Jeffrey E Teigler; Stephen Blackmore; Lily Parenteau; Kshitij Wagh; Scott A Handley; Guoyan Zhao; Herbert W Virgin; Bette Korber; Dan H Barouch
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

Review 10.  Circumventing antivector immunity: potential use of nonhuman adenoviral vectors.

Authors:  Estrella Lopez-Gordo; Iva I Podgorski; Nicholas Downes; Ramon Alemany
Journal:  Hum Gene Ther       Date:  2014-03-25       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.